NCT03915951 2026-03-24An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung CancerPfizerPhase 2 Completed98 enrolled 18 charts 2 FDA
NCT03898908 2025-05-21EBRAIN-MELGrupo Español Multidisciplinar de MelanomaPhase 2 Completed48 enrolled 24 charts